New York is currently home to 4503 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
Recruiting
The goal of this clinical trial is to compare the efficacy of the electromyography component of the company's pelvic health product in a patient population with stress urinary incontinence to treatment with pelvic floor physical therapy. The main questions it aims to answer are: Does treatment with the device under study improve symptoms of stress urinary incontinence as measured by the ICIQ when compared to pelvic floor physical therapy? Does treatment with the device under study combined wi... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
03/28/2024
Locations: Pelex, Little Neck, New York
Conditions: Stress Urinary Incontinence, Pelvic Floor Disorders
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Recruiting
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
03/28/2024
Locations: Northwell Health, New Hyde Park, New York
Conditions: Lung Cancer
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Recruiting
This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants on active surveillance.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
03/27/2024
Locations: Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York
Conditions: Prostate Cancer Patients on Active Surveillance
Tau Biomarkers in Late-onset Psychosis (LOP)
Recruiting
Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.
Gender:
ALL
Ages:
Between 65 years and 85 years
Trial Updated:
03/27/2024
Locations: The Feinstein Institutes for Medical Research, Manhasset, New York
Conditions: Late Onset Schizophrenia, Delusional Disorder (Late Onset)
Pediatric Percutaneous Ultrasound Gastrostomy Technique
Recruiting
The purpose of this research study is to test a new device called the PUMA-G Pediatric System. The research will measure if the device works well to safely aid doctors placing gastrostomy feeding tubes in children. The PUMA-G Pediatric System is an investigational device that uses ultrasound and magnets to guide insertion of a feeding tube.
Gender:
ALL
Ages:
Between 0 years and 21 years
Trial Updated:
03/27/2024
Locations: Nyph/Cumc, New York, New York
Conditions: Gastrostomy, Gastrostomy Complications, Pediatric Disorder, Ultrasound
CERAMENTâ„¢| Bone Void Filler Device Registry
Recruiting
A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: The Research Foundation of The State University of New York, Syracuse, New York
Conditions: Orthopedic Disorder
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Recruiting
This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine c... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/25/2024
Locations: New York Proton Center, New York, New York
Conditions: Thoracic Cancer
Human Blood Cell Disorders Tissue Bank
Recruiting
The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in the... Read More
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
03/25/2024
Locations: The Feinstein Institute for Medical Research, Manhasset, New York
Conditions: Human Blood Cell Disorders, Lymphoid, Myeloid and Erythroid Proliferative Disease
Defibrotide Dose-escalation for SOS Post-HSCT
Recruiting
This research study is being done to determine the safety and tolerability of increasing doses of defibrotide within a single patient with sinusoidal obstructive syndrome (SOS)/veno-occlusive disease (VOD) after hematopoietic cell transplantation (HCT) associated with either kidney and/or lung impairment that has not obtained a complete response (CR) or progressed in severity with standard doses of defibrotide.
Gender:
ALL
Ages:
Between 1 month and 75 years
Trial Updated:
03/22/2024
Locations: New York Medical College, Valhalla, New York
Conditions: Sinusoidal Obstruction Syndrome, Veno-occlusive Disease
Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.
Recruiting
This is a Phase 1b, single-center, open-label study, evaluating efficacy and safety of RP1 for the treatment of resectable cutaneous Squamous Cell Carcinoma in up to 12 evaluable patients. In this study, patients will receive RP1 via direct intratumoral (IT) injection into superficial cutaneous solid tumors to assess the safety and tolerability as well efficacy of RP1 treatment. The primary efficacy population is up to 12 evaluable patients with resectable CSCC. The enrollment of patients with C... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: Rochester Dermatologic Surgery, Victor, New York
Conditions: Squamous Cell Carcinoma, RP1
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
Recruiting
While most studies in the medical literature that indicate "music" as an intervention may recognize its impact and capacity to decrease pain perception, anxiety, and/or its role in the regulation of cardiac and respiratory function in ICU patients, no identifiable studies have implemented entrained live music therapy protocols into clinical trials. Music therapy treatment is a non-pharmacological intervention that is individually tailored to the patient's needs and focuses on the assessment and... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: Mount Sinai West, New York, New York
Conditions: Acute Respiratory Distress Syndrome, Acute Hypoxemic Respiratory Failure, Acute Hypercapnic Respiratory Failure
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
Recruiting
The standard treatment for patients with Non-Small Cell Lung Cancer (NSCLC) and clinically negative lymph nodes remains surgery per current guidelines. Five year survival for patients with stage I non-small cell lung cancer is generally greater than 50% after surgery. Many of these patients have heart and lung issues or other diseases which keep them from undergoing curative surgery. Studies have shown that majority of these patients die from their cancer and not from their other diseases. This... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: SUNY Upstate Medical University, Syracuse, New York
Conditions: Non-small Cell Lung Cancer